RFP
SUPN icon

Root Financial Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Root Financial Partners’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.03K Buy
78
+13
+20% +$662 ﹤0.01% 2030
2025
Q4 		$3.23K Buy
65
+2
+3% +$97 ﹤0.01% 1885
2025
Q3 		$3.01K Buy
+63
New +$2.54K ﹤0.01% 1881

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Root Financial Partners's SUPN Position: Q1 2026 in Review

Root Financial Partners increased its Supernus Pharmaceuticals (SUPN) stake by 20% in Q1 2026, buying an estimated $662 and bringing the position to 78 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Root Financial Partners first reported a position in SUPN in Q3 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Root Financial Partners held 78 shares of Supernus Pharmaceuticals worth $4.03K as of Q1 2026.
  • Root Financial Partners bought 13 Supernus Pharmaceuticals shares in Q1 2026, an estimated $662.
  • Supernus Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2030 holding.
  • Root Financial Partners first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.